The aim of the present study was to identify the role of miRNAs in end-stage renal disease (ESRD) patients with CKD-MBD and to elucidate possible links between miRNAs and the traditional bone turnover serum marker PTH. The gene discussed is PTH; the disease is Marchiafava-Bignami disease.